Aethlon Medical (AEMD:NASDAQ) Annual Reports & Investor Relations Material

Overview

Aethlon Medical, Inc., a San Diego-based medical technology firm, is on a mission to create innovative products that can help diagnose and treat life-threatening diseases. Their flagship product, the Aethlon Hemopurifier, is a clinical-stage immunotherapy device designed to remove tumor-derived exosomes and viruses that pose a risk to human lives and organs from the circulatory system. Specifically, the product is capable of removing COVID-19 virus, associated variants, and associated exosomes. The company has also partnered with the University of Pittsburgh Medical Center Hillman Cancer Center for research relating to head and neck cancer. Founded in 1999, Aethlon Medical, Inc. is at the forefront of medical technology and is committed to creating products that can help save lives.

Frequently Asked Questions

What is Aethlon Medical's ticker?

Aethlon Medical's ticker is AEMD

What exchange is Aethlon Medical traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Aethlon Medical's headquarters?

They are based in San Diego, California

How many employees does Aethlon Medical have?

There are 11-50 employees working at Aethlon Medical

What is Aethlon Medical's website?

It is aethlonmedical.com/about

What type of sector is Aethlon Medical?

Aethlon Medical is in the Healthcare sector

What type of industry is Aethlon Medical?

Aethlon Medical is in the Medical Appliances & Equipment industry

Who are Aethlon Medical's peers and competitors?

The following five companies are Aethlon Medical's industry peers:

- Rockwell Medical

- Apollo Endosurgery

- MSA Safety

- Clearpoint Neuro

- Digirad Corporation